Hannah Evans, the NHS body’s director of planning, said while its intention is as many services are provided “close to home”, and it intends extending the range of services offered from sites, that ...

Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer's Disease 56% of Patients with Low Tau ...

Leveraging their healthcare knowledge and industry connections eased the family burden associated with navigating through end ...

A brand-new medical center is set to open its doors in Geneva Sept. 15 — and Rochester Regional Health describes its Geneva ...

The global Nuclear Medicine Software Market, valued at US$887.5 million in 2024 stood at US$970.0 million in 2025 and is projected to advance ...

Philips is advancing its role as a trusted partner in integrated diagnostics, scaling analytics and driving workflow ...

Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter in patients with mild to moderate ...

Düsseldorf, Germany and Gothenburg, Sweden – 8 July 2025 – Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, ...

Made Scientific is a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy.